#     Find Funding Opportunities  

## Primary tabs

- Open Opportunities
- Closed Opportunities
- Notices

**COVID-19 Funding Notices | Approved Initiative Concepts | Research Opportunity Announcements

All NINDS-related notices of funding opportunities (NOFOs), request for applications (RFAs), program announcements (PAs), and other NIH Guide announcements are listed. Search the Closed Opportunities tab to find expired opportunities. Search the Notices tab to find all Notices.

Learn more about award types and program directors and managers.

NINDS has a number of open positions for researchers and clinicians to contribute to exciting neuroscience programs - APPLY NOW!

For more focused results add quotes to indicate parameters. Example format: "search term".

HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
Research Category: HEAL Initiative, PainExpiration Date: Friday, January 8, 2027NOFO Number: RFA-NS-24-019Release Date: Tuesday, October 31, 2023Notice Type: RFA

Reissue of RFA-NS-20-010: The purpose of this funding opportunity announcement (FOA) is to support preclinical optimization and development of safe, effective, and non-addictive small molecule and biologic therapeutics to treat pain. The goal of the program is to accelerate the optimization and development of promising small molecule and biologic hits/leads towards clinical trials. Applicants must have a promising hit/lead, robust biological rationale for the intended approach, and identified assays for optimization of the agent. The scope of this program includes optimization and early development activities, IND-enabling studies, and assembly of Investigational New Drug (IND) application. This is a milestone-driven phased cooperative agreement program involving participation of NIH program staff in the development of the project plan and monitoring of research progress.

Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
Expiration Date: Thursday, November 19, 2026NOFO Number: PAR-23-294Release Date: Monday, October 30, 2023Notice Type: PAR

Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
Expiration Date: Thursday, November 19, 2026NOFO Number: PAR-23-293Release Date: Monday, October 30, 2023Notice Type: PAR

Health and Health Care Disparities Among Persons Living with Disabilities (R01 - Clinical Trials Optional)
Expiration Date: Friday, November 6, 2026NOFO Number: PAR-23-309Release Date: Tuesday, September 26, 2023Notice Type: PAR

BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)
Expiration Date: Tuesday, June 16, 2026NOFO Number: RFA-EY-23-001Release Date: Tuesday, September 19, 2023Notice Type: RFA

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity)
Research Category: PainExpiration Date: Monday, September 8, 2025NOFO Number: PA-23-271Release Date: Tuesday, September 12, 2023Notice Type: PA

The purpose of this Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research award is to enhance the diversity of the health-related research workforce by supporting the research training of predoctoral students from diverse backgrounds including those from groups that are underrepresented in the biomedical, behavioral, or clinical research workforce. Through this award program, promising predoctoral students will obtain individualized, mentored research training from outstanding faculty sponsors while conducting well-defined research projects in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The proposed mentored research training is expected to clearly enhance the individual's potential to develop into a productive, independent research scientist. This Notice of Funding Opportunity (NOFO) does not allow candidates to propose to lead an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial, but does allow candidates to propose research experience in a clinical trial led by a sponsor or co-sponsor.

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)
Research Category: PainExpiration Date: Monday, September 8, 2025NOFO Number: PA-23-261Release Date: Thursday, September 7, 2023Notice Type: PA

This Notice of Funding Opportunity (NOFO) will support students at institutions without NIH-funded institutional predoctoral dual-degree training programs. The purpose of the Kirschstein-NRSA, dual-doctoral degree, predoctoral fellowship (F30) is to enhance the integrated research and clinical training of promising predoctoral students, who are matriculated in a combined MD/PhD or other dual-doctoral degree training program (e.g. DO/PhD, DDS/PhD, AuD/PhD, DVM/PhD), and who intend careers as physician/clinician-scientists. Candidates must propose an integrated research and clinical training plan and a dissertation research project in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The fellowship experience is expected to clearly enhance the individual's potential to develop into a productive, independent physician/clinician-scientist. This NOFO is designed specifically for candidates proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial, but does allow candidates to propose research experience in a clinical trial led by a sponsor or co-sponsor.

Notice of Special Interest (NOSI): Research Supplements to Promote Re-Entry, Re-integration into, and Re-training in Health-Related Research Careers (Admin Supp - Clinical Trial Not Allowed)
Expiration Date: Friday, October 9, 2026NOFO Number: NOT-OD-23-170Release Date: Wednesday, September 6, 2023Notice Type: Notice of Special Interest

Enhancement and Management of Established Biomedical Data Repositories and Knowledgebases (U24 Clinical Trial Not Allowed)
Expiration Date: Monday, January 26, 2026NOFO Number: PAR-23-237Release Date: Wednesday, August 30, 2023Notice Type: PAR

Early-stage Biomedical Data Repositories and Knowledgebases (R24 Clinical Trial Not Allowed)
Expiration Date: Monday, January 26, 2026NOFO Number: PAR-23-236Release Date: Wednesday, August 30, 2023Notice Type: PAR

#### Pagination

-  « FirstFirst page 
-  ‹‹Previous page 
-  3 
-  4 
-  5 
-  6 
-  7 
-  8 
-  9 
-  ››Next page 
-  Last »Last page 

    CSV  

    JSON  

    XLSX  

        RSS